18
Views
10
CrossRef citations to date
0
Altmetric
Article

Etiology and Therapy of Community-Acquired Pneumonia

Pages 285-292 | Published online: 18 Jul 2013
 

Abstract

The Authors report the data of a retrospective study performed on 520 patients admitted to the Institute of Respiratory Diseases, University of Sassari, Italy, for community acquired pneumonia (CAP) from 1980 to 1995.

The aim of this study was to investigate:

- the frequency of risk factors and their impact on severity of pneumonia;

- the frequency of pathogens and their correlation with the severity of the illness;

- antibiotic treatments.

One or more risk factors were found in 86% of patients, while 14% had none. In 286 patients (55%) no etiological diagnosis was possible, while in 234 patients (45%) the pathogen was identified. Of the latter, 73% suffered from pneumonia caused by Gram-negative bacilli, 24% by Gram-positive organisms, 0.8% by Mycoplasma pneumoniae and 1.7% by respiratory viruses and endemic fungi. The mortality rate found was 2.69%. In this study, pneumonia caused by Gram-negative bacilli showed a plurilobar and often bilateral involvement, frequent resistance to the most common antibiotics, which required longer hospitaliza-tion (>30 days). The high prevalence of pneumonia caused by Gram-negative bacilli can be explained by the presence, in most of the patients, of serious and numerous risk factors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.